STV H1 2026 slides: ad revenue rises as studios face impairment
Source: Investing.com

STV reported H1 2026 revenue of £66.1 million, down 27% year over year, and adjusted operating profit of £5.9 million, down 12%, as a 63% drop in studios revenue to £15.5 million outweighed 5% advertising growth. A £25.4 million non-cash impairment in STV Studios and a £3.2 million divisional operating loss drove shares 6.7% lower, although adjusted EPS held at 7.1p and net debt declined to £42.9 million. Management expects Q3 advertising revenue to fall about 5%, Studios to breakeven for FY2026, and withheld an interim dividend to preserve balance-sheet flexibility.
Analysis
The key valuation issue is that STVG is increasingly being priced as a cyclical UK production asset rather than as a local-audience advertising platform. That discount can persist because the production recovery depends on a concentrated set of commissioning decisions, while the audience business faces a tougher comparison period and regional advertising softness. A 5% Q3 advertising decline would matter disproportionately: the audience division is carrying group profitability, so even modest revenue misses could erase the margin benefit from mix and cost actions.
Studios’ impairment is non-cash, but it is economically important because it resets expectations for the asset’s earnings power and signals lower confidence in forecast cash flows. The balance-sheet risk is not an immediate covenant event; it is the December 2027 pension step-up coinciding with refinancing/interest-rate exposure and potentially still-subscale studio cash generation. That makes free-cash-flow conversion, rather than adjusted EPS, the relevant metric over the next 12-18 months.
The less obvious beneficiary of a prolonged UK commissioning drought is NFLX: fewer credible independent buyers increase platform bargaining power on rights, delivery terms and renewal economics. Conversely, STVG’s multi-platform local inventory may be strategically valuable to META and Alphabet-style digital advertisers, but only if self-service targeting can win incremental SME budgets rather than cannibalize higher-yield broadcast sales. Consensus may underappreciate this option value, yet it is not investable until management discloses digital advertising yield, customer retention and product monetization.
Near term, STVG is likely catalyst-poor after the impairment; the market needs either sequential advertising stabilization or a material international commission to underwrite 2027 studios profitability. A sharp UK ad-market recovery would reverse the bearish view, but absent that, lower guidance risk and no income-support catalyst argue against buying the initial selloff.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.38
Ticker Sentiment
Key Decisions for Investors
- Maintain an underweight/short bias in STVG through the Q3 trading update and FY2026 guidance window; use any rally on audience-growth metrics to initiate rather than chase weakness. Thesis target is further multiple compression if advertising guidance is reduced or studios breakeven slips; stop out on a material multi-season international commission plus stable Q4 advertising.
- For liquid UK exposure, express the relative view as long ITV.L / short STVG only after confirming comparable valuation and borrow availability. ITV offers greater scale in advertising sales and production-library monetization; risk is that STVG's local-market audience resilience produces a faster ad rebound. Review over 3-6 months.
- Do not position in STVG solely on the impairment-driven decline. Set alerts for Q3 advertising performance, net debt versus the £40-45m year-end range, and disclosure of contracted 2027 studio revenue; a sustained advertising beat combined with incremental orderbook growth would warrant reassessing for a 6-18 month recovery long.
- Maintain a modest constructive bias on NFLX versus UK independent producers over 6-12 months: constrained commissioning supply should improve buyer leverage, but do not attribute a material earnings impact without evidence of lower content-cash-spend intensity or improved amortization economics.